Home
 
Cross Atlantic Partners (CAP) actively manages private equity venture funds for investment in developing healthcare and life sciences companies in the United States. We focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.

Since our founding in 1994, CAP has achieved an aggregate 36.9% compound internal rate of return (IRR)
and a 2.3X cash-on-cash return on completed investments.
 
Newsletter Sign Up
About | Investment Focus | Investment Criteria | Team | Active Investments | Exited Investments | News | Contact Us

551 Madison Avenue, 7th Floor New York, NY 10022 © 2008 Company.com. All rights reserved.